Chronomics
London
About Chronomics
Chronomics is a tech-bio company on a mission to make biology accessible and actionable to everyone. The world is at the dawn of a ‘bio-revolution’ - with science set to transform our lives in the coming decades. And yet today, accessing biological information - and making it actionable - is complex, costly and cumbersome. The revolution needs an engine - and we are building it. We design and deploy ‘bio-infrastructure’ across more than a dozen verticals to simplify, speed-up and scale the use of biomarkers to improve everyday decisions. From tele-health to travel; sleep to skincare; multivitamins to managing menopause - and many others - we partner with the world’s largest and most impactful organizations, using science to transform how they diagnose, personalize and evaluate their offerings. Co-located between the US and Europe, we’re a team that spans science, technology, supply chain, operations, commercial - and we’re growing. Rapidly.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Jan 2019)
- Website: chronomics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/chronomics-114690 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.